Curi Bio is presenting AAV capsid screening data at a webinar with Dyno Therapeutics on Wednesday, September 23 at 8 AM PT.

Public source

Publisher name

Public post

Happy #FluorescenceFriday! 🔬💪 One plate, 96 human iPSC-derived engineered skeletal muscle tissues, and a panel of in vivo validated myotropic AAV capsids from Dyno The…

Log in to read the full post

Company

Curi Bio

Human Data for Next Generation Medicines

Industry
Biotechnology Research
Location
Seattle, US
Company size
51–200 employees

About Curi Bio

"Human Data for Next Generation Medicines" Curi Bio unlocks novel workflows and critical human data to inform R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for drug safety, efficacy, and potency

See more

Latest activity

10 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.